Indrajit Fernando
YOU?
Author Swipe
View article: A79 EAT, SLEEP, WORK, REPEAT! WEARABLES AND APPS TO TRACK IBD PATIENTS’ SYMPTOMS, DIET, SLEEP, AND PHYSICAL ACTIVITY
A79 EAT, SLEEP, WORK, REPEAT! WEARABLES AND APPS TO TRACK IBD PATIENTS’ SYMPTOMS, DIET, SLEEP, AND PHYSICAL ACTIVITY Open
Background Lifestyle factors like diet, physical activity, and sleep patterns are known to influence symptoms and progression in Inflammatory Bowel Disease (IBD). However, accurately determining temporal relationships between these factors…
View article: #863 The role of pegylated liposomal doxorubicin and weekly paclitaxel with or without bevacizumab in prolonging the platinum-free interval in epithelial ovarian cancer
#863 The role of pegylated liposomal doxorubicin and weekly paclitaxel with or without bevacizumab in prolonging the platinum-free interval in epithelial ovarian cancer Open
Introduction/Background Platinum-free interval predicts subsequent platinum sensitivity and is a prognostic factor in ovarian cancer. The aim of the study is to investigate response to non platinum-agents in platinum-resistant disease and …
View article: Detailed Sub-study Analysis of the SECRAB Trial: Quality of Life, Cosmesis and Chemotherapy Dose Intensity
Detailed Sub-study Analysis of the SECRAB Trial: Quality of Life, Cosmesis and Chemotherapy Dose Intensity Open
View article: 2022-VA-1059-ESGO Omental flap as a spacer to reduce acute bowel toxicity after adjuvant radiotherapy
2022-VA-1059-ESGO Omental flap as a spacer to reduce acute bowel toxicity after adjuvant radiotherapy Open
View article: 2022-RA-1042-ESGO The prognostic impact of anaemia in cervical cancer patients treated with chemoradiation
2022-RA-1042-ESGO The prognostic impact of anaemia in cervical cancer patients treated with chemoradiation Open
View article: Response to Gultekin et al. regarding SECRAB trial toxicity
Response to Gultekin et al. regarding SECRAB trial toxicity Open
View article: Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial
Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial Open
View article: Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial
Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial Open
View article: Diabetic ketoacidosis after treatment with pembrolizumab
Diabetic ketoacidosis after treatment with pembrolizumab Open
View article: Hypoglyceamia in a Patient with a Solitary Fibrous Tumour
Hypoglyceamia in a Patient with a Solitary Fibrous Tumour Open
Objective: To illustrate an unusual mechanism causing hypoglycaemia. Material and methods: A 76-year-old man presented with episodes of agitation and confusion and was resuscitated with oral glucose gel when found to be hypoglycaemic. Resu…